MarketCap
Facebook
X
Telegram
Allakos EV | ALLK
EV Jährlich Allakos
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 K | 122 M | 324 M | 464 M | 6.79 B | 3.46 B | 747 M | 60.6 M | 37.2 M | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.79 B | 31 K | 1.33 B |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Sanofi
SNY
|
51.6 B | $ 41.77 | 0.41 % | $ 51 B |  France |
 |
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 31.74 | 1.73 % | $ 4.04 B |  USA |
 |
Geron Corporation
GERN
|
1.33 B | $ 1.15 | 2.23 % | $ 767 M | USA |
 |
Gossamer Bio
GOSS
|
365 M | $ 9.2 | -4.27 % | $ 2.1 B | USA |
 |
Titan Pharmaceuticals
TTNP
|
-2.35 M | - | -3.76 % | $ 3.47 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
11.9 M | - | 3.16 % | $ 1.9 M | USA |
 |
ALX Oncology Holdings
ALXO
|
131 M | $ 1.14 | -2.56 % | $ 61.2 M | USA |
 |
Heron Therapeutics
HRTX
|
411 M | $ 0.3 | -0.46 % | $ 50 M | USA |
 |
Achieve Life Sciences
ACHV
|
126 M | $ 6.55 | 0.85 % | $ 286 M | USA |
 |
TCR2 Therapeutics
TCRR
|
92.6 M | - | - | $ 58.1 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
1.95 B | $ 17.02 | 0.98 % | $ 2.29 B |  Canada |
 |
iBio
IBIO
|
98.5 M | $ 0.71 | -1.28 % | $ 73.9 M | USA |
 |
ImmuCell Corporation
ICCC
|
69.7 M | $ 10.21 | -0.37 % | $ 92.2 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
4.14 B | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
Inhibikase Therapeutics
IKT
|
-10.3 M | $ 1.51 | -5.03 % | $ 148 M | USA |
 |
Immunome
IMNM
|
1.28 B | $ 17.89 | -0.54 % | $ 1.56 B | USA |
 |
TFF Pharmaceuticals
TFFP
|
7.83 M | - | -60.05 % | $ 125 K | USA |
 |
InMed Pharmaceuticals
INM
|
5.21 M | $ 1.57 | 9.03 % | $ 6.54 M | Canada |
 |
Inovio Pharmaceuticals
INO
|
104 M | $ 0.88 | -1.82 % | $ 41.3 M | USA |
 |
Innoviva
INVA
|
1.07 B | $ 21.06 | 1.91 % | $ 1.42 B | USA |
 |
Iovance Biotherapeutics
IOVA
|
52.9 M | $ 13.78 | -2.24 % | $ 4.92 M | USA |
 |
Theratechnologies
THTX
|
62.7 M | - | - | $ 83.9 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
143 M | - | -15.15 % | $ 60.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
111 M | - | - | $ 521 M | USA |
 |
Axon Enterprise
AXON
|
33.2 B | $ 424.81 | 1.06 % | $ 33.2 B | USA |
 |
Axcella Health
AXLA
|
22.6 M | - | -16.42 % | $ 249 M | USA |
 |
Keros Therapeutics
KROS
|
261 M | $ 11.35 | 0.62 % | $ 422 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.02 B | - | - | $ 2.02 B | USA |
 |
Legend Biotech Corporation
LEGN
|
6.74 B | $ 20.39 | 5.79 % | $ 7.52 B | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
2.33 B | $ 308.16 | 1.53 % | $ 5.96 B | USA |
 |
BridgeBio Pharma
BBIO
|
15.5 B | $ 68.11 | -0.65 % | $ 13 B | USA |
 |
Annovis Bio
ANVS
|
36.5 M | $ 0.95 | -4.92 % | $ 19.5 M | USA |
 |
Liquidia Corporation
LQDA
|
3.04 B | $ 43.75 | 2.58 % | $ 3.77 B | USA |
 |
Tyme Technologies
TYME
|
-5.81 M | - | 8.07 % | $ 54 M | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
635 M | $ 1.46 | 2.81 % | $ 530 M | USA |
 |
Mustang Bio
MBIO
|
-5.03 M | $ 0.36 | -1.89 % | $ 1.77 M | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
2.8 B | $ 7.88 | 3.01 % | $ 1.65 B | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
10.3 B | $ 437.59 | 0.77 % | $ 9.82 B | USA |
 |
Cyclerion Therapeutics
CYCN
|
10.1 M | $ 34.99 | 3.77 % | $ 147 M | USA |
 |
Black Diamond Therapeutics
BDTX
|
134 M | $ 1.69 | -10.37 % | $ 96.1 M | USA |
 |
Mirum Pharmaceuticals
MIRM
|
5.68 B | $ 83.44 | 3.79 % | $ 4.19 B | USA |
 |
Aptevo Therapeutics
APVO
|
-10.4 M | $ 1.49 | -7.45 % | $ 470 K | USA |
 |
MannKind Corporation
MNKD
|
1.76 B | $ 3.23 | 1.25 % | $ 987 M | USA |
|
Monopar Therapeutics
MNPR
|
342 M | $ 70.52 | -0.18 % | $ 523 M | USA |
 |
Marker Therapeutics
MRKR
|
6.72 M | $ 0.9 | -6.16 % | $ 13.8 M | USA |
 |
Maravai LifeSciences Holdings
MRVI
|
488 M | $ 7.5 | 3.69 % | $ 1.08 B | USA |
 |
Matinas BioPharma Holdings
MTNB
|
1.12 M | $ 1.66 | -2.92 % | $ 9.09 M | USA |
 |
Neurocrine Biosciences
NBIX
|
665 M | $ 145.91 | 2.25 % | $ 14.5 B | USA |
 |
Orgenesis
ORGS
|
38.8 M | - | -33.86 % | $ 61.2 M | USA |
 |
Biogen
BIIB
|
37.6 B | $ 252.25 | 0.62 % | $ 37 B | USA |